SEC Form 4 · accession 0001104659-18-062553
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Murray Stewart
Officer — Chief Medical Officer
Period of report
Oct 15, 2018
Accepted (ET)
Oct 17, 2018 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649904
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $26.54 | Oct 15, 2018 | A | 100,000 | A | — | Oct 14, 2028 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option vests as follows: (1) 25% on October 15, 2019, and (2) the remaining 75% in 12 equal quarterly installments.